Munich, Germany – The latest, innovative product release from ibidi is the µ-Dish 35 mm Quad, a four-compartment cell culture dish that can be used for simultaneous assays, and it guarantees brilliant optical quality. Using this 35 mm imaging dish, researchers will benefit significantly from the quartered construction: the subdivisions enable up to four parallel, individual experiments in […]

Symcel secures €3.6 million Horizon 2020 Phase II grant for clinical validation of customized antimicrobial susceptibility testing Multi-resistant bacterial sepsis infections to be validated utilising Symcel’s sensitive screening technology Symcel, the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, calScreener™, has secured €3.572 million Horizon 2020 funding to support the company’s evaluation […]

MANASSAS, VA – ATCC, an established and trusted source of biological materials in the R&D community, today announced the release of an innovative, in vitro model system for a key mechanism of invasion and metastasis in lung cancer. This model is part of a larger effort by ATCC researchers to develop a portfolio of clinically relevant models […]

MINNEAPOLIS — Bio-Techne updated its Flow Cytometry Panel Builder tool in July 2017 to support the use of its vast selection of over 18,000 conjugated antibodies, across targets and colors. The Flow Cytometry Panel Builder, a version of the FluoroFinder tool, was first launched in 2014 when this tool first became available to the scientific community. […]

AMSBIO has introduced a new range of Herpes Virus Entry Mediator (HVEM) products for use in immuno-oncology research. These new products will be of great interest to researchers studying TNFR family members such as CD137 (4-1BB), GITR, OX40, CD27, and other co-stimulatory proteins involved in B and T cell development, immune activation, and antitumor immune […]

The European Commission has appointed Phase Holographic Imaging, Bundesanstalt für Material-forschung und Prüfung (Germany’s federal technology research institute), Malmö, Umeå, Copenhagen and Turku University to develop improved methods for clinically diagnosing cancer. The €2.1 million grant finances a three-year research project which is coordinated by Malmö University and commercialized by Phase Holographic Imaging (PHI). Current methods for […]

New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types Exclusive IP licensed from the University of Cambridge Geographically diversified, top-tier investor team includes key industry leaders to support early company development Cambridge, UK: Elpis BioMed, a University of Cambridge spin-out, applying its disruptive and proprietary “direct cell […]

IsoPlexis will use four new NIH grants to advance research and development of immunotherapies to treat solid tumors, bone marrow disease, autoimmune diseases and infectious diseases. Branford, Conn.—IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology and the immune-based cancer treatment revolution, announced today that it has received […]

Dolomite Bio is delighted to announce the launch of the game-changing Nadia single cell platform, a groundbreaking system set to escalate scRNA-Seq to new heights, offering the fast-growing single cell research sector an innovative solution for a wide range of potential applications. This novel product family will be on display from the 9th to the 10th of […]

PARIS—Scipio bioscience, a Paris-based biotechnology company devoted to providing a novel sample preparation solution for single-cell studies in the form of benchtop kits, announces today the completion of its initial fundraising. A total of €1.2m has been obtained from two European seed funds: Paris, France-based Seventure Partners’ Quadrivium I seed fund and Bonn, Germany-based High-Tech […]